Safety, tolerability, and immunogenicity of influenza vaccination with a high- density microarray patch: Results from a randomized, controlled phase I clinical trial - MD Linx

Safety, tolerability, and immunogenicity of influenza vaccination with a high- density microarray patch: Results from a randomized, controlled phase I clinical trial  MD Linx

Comments

Popular posts from this blog

Global Influenzavirus B Infection Drug Market 2019 - AbbVie Inc, Adimmune Corp, Altravax Inc, Amarillo Biosciences Inc, Aphios Corp Business Pulze - Business Pulze

Healthcare layoff tracker—Walmart cuts 74 virtual health jobs - Fierce healthcare